pERK, pAKT and p53 as tissue biomarkers in erlotinib-treated patients with advanced pancreatic cancer: a translational subgroup analysis from AIO-PK0104
The role of pERK, pAKT and p53 as biomarkers in patients with advanced pancreatic cancer has not yet been defined.
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
28 August 2014
|
| In: |
BMC cancer
Year: 2014, Volume: 14 |
| ISSN: | 1471-2407 |
| DOI: | 10.1186/1471-2407-14-624 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1186/1471-2407-14-624 Verlag, lizenzpflichtig, Volltext: https://bmccancer.biomedcentral.com/articles/10.1186/1471-2407-14-624 
|
| Author Notes: | Steffen Ormanns, Jens T. Siveke, Volker Heinemann, Michael Haas, Bence Sipos, Anna Melissa Schlitter, Irene Esposito, Andreas Jung, Rüdiger P. Laubender, Stephan Kruger, Ursula Vehling-Kaiser, Cornelia Winkelmann, Ludwig Fischer von Weikersthal, Michael R. Clemens, Thomas C. Gauler, Angela Märten, Michael Geissler, Tim F. Greten, Thomas Kirchner and Stefan Boeck |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1729056881 | ||
| 003 | DE-627 | ||
| 005 | 20230126153819.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 200908s2014 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/1471-2407-14-624 |2 doi | |
| 035 | |a (DE-627)1729056881 | ||
| 035 | |a (DE-599)KXP1729056881 | ||
| 035 | |a (OCoLC)1341358908 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Ormanns, Steffen |d 1982- |e VerfasserIn |0 (DE-588)1188594117 |0 (DE-627)1667545418 |4 aut | |
| 245 | 1 | 0 | |a pERK, pAKT and p53 as tissue biomarkers in erlotinib-treated patients with advanced pancreatic cancer |b a translational subgroup analysis from AIO-PK0104 |c Steffen Ormanns, Jens T. Siveke, Volker Heinemann, Michael Haas, Bence Sipos, Anna Melissa Schlitter, Irene Esposito, Andreas Jung, Rüdiger P. Laubender, Stephan Kruger, Ursula Vehling-Kaiser, Cornelia Winkelmann, Ludwig Fischer von Weikersthal, Michael R. Clemens, Thomas C. Gauler, Angela Märten, Michael Geissler, Tim F. Greten, Thomas Kirchner and Stefan Boeck |
| 246 | 3 | 3 | |a pERK, pAKT and p fifty-three as tissue biomarkers in erlotinib-treated patients with advanced pancreatic cancer |
| 264 | 1 | |c 28 August 2014 | |
| 300 | |a 10 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 09.09.2020 | ||
| 520 | |a The role of pERK, pAKT and p53 as biomarkers in patients with advanced pancreatic cancer has not yet been defined. | ||
| 700 | 1 | |a Siveke, Jens T. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Heinemann, Volker |e VerfasserIn |4 aut | |
| 700 | 1 | |a Haas, Michael |e VerfasserIn |4 aut | |
| 700 | 1 | |a Sipos, Bence |e VerfasserIn |4 aut | |
| 700 | 1 | |a Schlitter, Anna Melissa |e VerfasserIn |4 aut | |
| 700 | 1 | |a Esposito, Irene |e VerfasserIn |4 aut | |
| 700 | 1 | |a Jung, Andreas |e VerfasserIn |4 aut | |
| 700 | 1 | |a Laubender, Rüdiger P. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kruger, Stephan |e VerfasserIn |4 aut | |
| 700 | 1 | |a Vehling-Kaiser, Ursula |e VerfasserIn |4 aut | |
| 700 | 1 | |a Winkelmann, Cornelia |e VerfasserIn |4 aut | |
| 700 | 1 | |a Fischer von Weikersthal, Ludwig |e VerfasserIn |4 aut | |
| 700 | 1 | |a Clemens, Michael R. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Gauler, Thomas C. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Märten, Angela |d 1968- |e VerfasserIn |0 (DE-588)122240103 |0 (DE-627)081822456 |0 (DE-576)293167931 |4 aut | |
| 700 | 1 | |a Geißler, Michael |d 1964- |e VerfasserIn |0 (DE-588)133573222 |0 (DE-627)548763305 |0 (DE-576)299942767 |4 aut | |
| 700 | 1 | |a Greten, Tim F. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kirchner, Thomas |e VerfasserIn |4 aut | |
| 700 | 1 | |a Boeck, Stefan |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t BMC cancer |d London : BioMed Central, 2001 |g 14(2014), Artikel-Nummer 624, 10 Seiten |h Online-Ressource |w (DE-627)326643710 |w (DE-600)2041352-X |w (DE-576)107014645 |x 1471-2407 |7 nnas |a pERK, pAKT and p53 as tissue biomarkers in erlotinib-treated patients with advanced pancreatic cancer a translational subgroup analysis from AIO-PK0104 |
| 773 | 1 | 8 | |g volume:14 |g year:2014 |g extent:10 |a pERK, pAKT and p53 as tissue biomarkers in erlotinib-treated patients with advanced pancreatic cancer a translational subgroup analysis from AIO-PK0104 |
| 856 | 4 | 0 | |u https://doi.org/10.1186/1471-2407-14-624 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://bmccancer.biomedcentral.com/articles/10.1186/1471-2407-14-624 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20200908 | ||
| 993 | |a Article | ||
| 994 | |a 2014 | ||
| 998 | |g 122240103 |a Märten, Angela |m 122240103:Märten, Angela |d 50000 |e 50000PM122240103 |k 0/50000/ |p 16 | ||
| 999 | |a KXP-PPN1729056881 |e 3747489362 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"person":[{"family":"Ormanns","given":"Steffen","roleDisplay":"VerfasserIn","display":"Ormanns, Steffen","role":"aut"},{"display":"Siveke, Jens T.","roleDisplay":"VerfasserIn","role":"aut","family":"Siveke","given":"Jens T."},{"display":"Heinemann, Volker","roleDisplay":"VerfasserIn","role":"aut","family":"Heinemann","given":"Volker"},{"role":"aut","display":"Haas, Michael","roleDisplay":"VerfasserIn","given":"Michael","family":"Haas"},{"roleDisplay":"VerfasserIn","display":"Sipos, Bence","role":"aut","family":"Sipos","given":"Bence"},{"family":"Schlitter","given":"Anna Melissa","display":"Schlitter, Anna Melissa","roleDisplay":"VerfasserIn","role":"aut"},{"given":"Irene","family":"Esposito","role":"aut","display":"Esposito, Irene","roleDisplay":"VerfasserIn"},{"role":"aut","display":"Jung, Andreas","roleDisplay":"VerfasserIn","given":"Andreas","family":"Jung"},{"role":"aut","display":"Laubender, Rüdiger P.","roleDisplay":"VerfasserIn","given":"Rüdiger P.","family":"Laubender"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Kruger, Stephan","given":"Stephan","family":"Kruger"},{"given":"Ursula","family":"Vehling-Kaiser","role":"aut","display":"Vehling-Kaiser, Ursula","roleDisplay":"VerfasserIn"},{"roleDisplay":"VerfasserIn","display":"Winkelmann, Cornelia","role":"aut","family":"Winkelmann","given":"Cornelia"},{"family":"Fischer von Weikersthal","given":"Ludwig","roleDisplay":"VerfasserIn","display":"Fischer von Weikersthal, Ludwig","role":"aut"},{"display":"Clemens, Michael R.","roleDisplay":"VerfasserIn","role":"aut","family":"Clemens","given":"Michael R."},{"display":"Gauler, Thomas C.","roleDisplay":"VerfasserIn","role":"aut","family":"Gauler","given":"Thomas C."},{"given":"Angela","family":"Märten","role":"aut","roleDisplay":"VerfasserIn","display":"Märten, Angela"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Geißler, Michael","given":"Michael","family":"Geißler"},{"family":"Greten","given":"Tim F.","roleDisplay":"VerfasserIn","display":"Greten, Tim F.","role":"aut"},{"family":"Kirchner","given":"Thomas","roleDisplay":"VerfasserIn","display":"Kirchner, Thomas","role":"aut"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Boeck, Stefan","given":"Stefan","family":"Boeck"}],"title":[{"title":"pERK, pAKT and p53 as tissue biomarkers in erlotinib-treated patients with advanced pancreatic cancer","subtitle":"a translational subgroup analysis from AIO-PK0104","title_sort":"pERK, pAKT and p53 as tissue biomarkers in erlotinib-treated patients with advanced pancreatic cancer"}],"note":["Gesehen am 09.09.2020"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"recId":"1729056881","language":["eng"],"titleAlt":[{"title":"pERK, pAKT and p fifty-three as tissue biomarkers in erlotinib-treated patients with advanced pancreatic cancer"}],"name":{"displayForm":["Steffen Ormanns, Jens T. Siveke, Volker Heinemann, Michael Haas, Bence Sipos, Anna Melissa Schlitter, Irene Esposito, Andreas Jung, Rüdiger P. Laubender, Stephan Kruger, Ursula Vehling-Kaiser, Cornelia Winkelmann, Ludwig Fischer von Weikersthal, Michael R. Clemens, Thomas C. Gauler, Angela Märten, Michael Geissler, Tim F. Greten, Thomas Kirchner and Stefan Boeck"]},"origin":[{"dateIssuedDisp":"28 August 2014","dateIssuedKey":"2014"}],"id":{"eki":["1729056881"],"doi":["10.1186/1471-2407-14-624"]},"physDesc":[{"extent":"10 S."}],"relHost":[{"id":{"issn":["1471-2407"],"eki":["326643710"],"zdb":["2041352-X"]},"origin":[{"publisher":"BioMed Central ; Springer","dateIssuedKey":"2001","dateIssuedDisp":"2001-","publisherPlace":"London ; Berlin ; Heidelberg"}],"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"BMC cancer","title":"BMC cancer"}],"part":{"text":"14(2014), Artikel-Nummer 624, 10 Seiten","volume":"14","extent":"10","year":"2014"},"pubHistory":["1.2001 -"],"language":["eng"],"recId":"326643710","note":["Gesehen am 22.05.20"],"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"pERK, pAKT and p53 as tissue biomarkers in erlotinib-treated patients with advanced pancreatic cancer a translational subgroup analysis from AIO-PK0104BMC cancer"}]} | ||
| SRT | |a ORMANNSSTEPERKPAKTAN2820 | ||